Read + Share
Amedeo Smart
Independent Medical Education
Yang YS, Jin X, Li Q, Chen YY, et al. Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression. Proc Natl Acad Sci U S A 2022;119:e2207201119.PMID: 36343244
Email
LinkedIn
Facebook
Twitter
Privacy Policy